Evidence map›Paper›PMID 33013655›Full record

ArticleFrontiers in neurology2020

The DQB1

Sarah Burkill, Kelsi A Smith, Pernilla Stridh, Ingrid Kockum, Jan Hillert, Hannes Lindahl, Lars Alfredsson, Tomas Olsson, Fredrik Piehl, Scott Montgomery and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Sarah BurkillDepartment of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Solna, Sweden.
Kelsi A SmithClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden.
Pernilla StridhDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Ingrid KockumDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Jan HillertDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Hannes LindahlDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Lars AlfredssonInstitute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
Tomas OlssonDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Fredrik PiehlDepartment of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Scott MontgomeryClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden.
Shahram BahmanyarDepartment of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Solna, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Murine models have demonstrated that the major histocompatibility complex (MHC) is associated with pain-like behavior in peripheral nerve injury, however, the same association has not been shown when considering injury to the central nervous system (CNS), which more closely mimics the damage to the CNS experienced by MS patients. Previous research has indicated the DQB1

Indexed as

cohort studyepidemiologygeneticsmultiple scleroisneurology

Identifiers

PMID33013655
PMCPMC7500133
OpenAlexW3083106771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.